BACKGROUND: Our aim was to monitor the impact of Roux-en-Y gastric bypass (RYGBP) on body composition over a 24-month period by dual-energy X-ray absorptiometry (DXA). METHODS: Forty-one women (40.6 ± 10.0 years old; 42.6 ± 6.6 kg/m(2)) entering a bariatric surgery programme were submitted to whole-body DXA (Lunar iDXA) before treatment and after 3, 6, 12 and 24 months. Fat mass (FM), non-bone lean mass (LM), bone mineral content (BMC) and density (BMD) were measured at whole body and regionally. Android visceral adipose tissue (VAT) was estimated by a recently validated software. RESULTS: Twenty-nine patients (44.3 ± 11.8 years old; BMI, 45.4 ± 8.9 kg/m(2)) concluded the study. Following surgery, the progressive decrease of BMI was associated with reduced whole-body and regional FM. LM showed a moderate decrease at 3 months and stabilized thereafter. A progressive decrease of total FM/LM and android FM/LM ratios were observed in the 3- to 6-month (-19.1 ± 8.4 % and -26.5 ± 10.9 %, respectively; p < 0.0001) and 6- to 12-month periods (-23.5 ± 16.8 % and -29.4 ± 23.9 %, respectively; p < 0.0001). VAT was the parameter showing the largest decrease (-65.6 ± 17.5 % at 12 months; p < 0.0001). Two years after the surgery, a slight but significant decrease of total and regional LM was observed, without any significant change in BMI. CONCLUSIONS: Body composition significantly changes after RYGBP with a metabolically healthier redistribution of total and regional FM and a positive balance of FM/LM variation. DXA should be considered as a valid supplementary tool for the clinical assessment and follow-up in patients undergoing bariatric surgery.
BACKGROUND: Our aim was to monitor the impact of Roux-en-Y gastric bypass (RYGBP) on body composition over a 24-month period by dual-energy X-ray absorptiometry (DXA). METHODS: Forty-one women (40.6 ± 10.0 years old; 42.6 ± 6.6 kg/m(2)) entering a bariatric surgery programme were submitted to whole-body DXA (Lunar iDXA) before treatment and after 3, 6, 12 and 24 months. Fat mass (FM), non-bone lean mass (LM), bone mineral content (BMC) and density (BMD) were measured at whole body and regionally. Android visceral adipose tissue (VAT) was estimated by a recently validated software. RESULTS: Twenty-nine patients (44.3 ± 11.8 years old; BMI, 45.4 ± 8.9 kg/m(2)) concluded the study. Following surgery, the progressive decrease of BMI was associated with reduced whole-body and regional FM. LM showed a moderate decrease at 3 months and stabilized thereafter. A progressive decrease of total FM/LM and android FM/LM ratios were observed in the 3- to 6-month (-19.1 ± 8.4 % and -26.5 ± 10.9 %, respectively; p < 0.0001) and 6- to 12-month periods (-23.5 ± 16.8 % and -29.4 ± 23.9 %, respectively; p < 0.0001). VAT was the parameter showing the largest decrease (-65.6 ± 17.5 % at 12 months; p < 0.0001). Two years after the surgery, a slight but significant decrease of total and regional LM was observed, without any significant change in BMI. CONCLUSIONS: Body composition significantly changes after RYGBP with a metabolically healthier redistribution of total and regional FM and a positive balance of FM/LM variation. DXA should be considered as a valid supplementary tool for the clinical assessment and follow-up in patients undergoing bariatric surgery.
Authors: David L Kendler; Joao L C Borges; Roger A Fielding; Akira Itabashi; Diane Krueger; Kathleen Mulligan; Bruno M Camargos; Brian Sabowitz; Chih-Hsing Wu; Elaine W Yu; John Shepherd Journal: J Clin Densitom Date: 2013-10-16 Impact factor: 2.617
Authors: Lisa K Micklesfield; Julia H Goedecke; Mark Punyanitya; Kevin E Wilson; Thomas L Kelly Journal: Obesity (Silver Spring) Date: 2012-01-12 Impact factor: 5.002
Authors: L G Machado; D S Domiciano; C P Figueiredo; V F Caparbo; L Takayama; R M Oliveira; J B Lopes; P R Menezes; R M R Pereira Journal: Osteoporos Int Date: 2016-06-28 Impact factor: 4.507
Authors: Artur Marc-Hernández; Jaime Ruiz-Tovar; Jose M Jimenez; Miguel A Carbajo; Maria Lopez; Maria J Cao; Maria J Castro Journal: Obes Surg Date: 2020-09 Impact factor: 4.129
Authors: Federico Ponti; Sara Guerri; Claudia Sassi; Giuseppe Battista; Giuseppe Guglielmi; Alberto Bazzocchi Journal: Endocrine Date: 2017-03-14 Impact factor: 3.633
Authors: Ina Gesquiere; Adam S Darwich; Bart Van der Schueren; Jan de Hoon; Matthias Lannoo; Christophe Matthys; Amin Rostami; Veerle Foulon; Patrick Augustijns Journal: Br J Clin Pharmacol Date: 2015-07-06 Impact factor: 4.335
Authors: Sara Guerri; Daniele Mercatelli; Maria Pilar Aparisi Gómez; Alessandro Napoli; Giuseppe Battista; Giuseppe Guglielmi; Alberto Bazzocchi Journal: Quant Imaging Med Surg Date: 2018-02